Replimune Group, Inc. — Director's Dealing 2019

Dec 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-11-26

Reporting Person: Kaufman Howard (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-26	Common Stock	M	58067	$3.3	Acquired	58067	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-26	Employee Stock Option (right to buy)	$3.3	M	58067	Disposed	2027-09-01	Common Stock (58067)	Direct

Footnotes

F1: On September 1, 2017 the Reporting Person was granted an option to purchase 149,202 shares of the Issuer's common stock, 25% of which vested on September 1, 2018 and the remainder of which vested or will vest in 36 equal monthly installments thereafter.